We found that above-median levels of RPL37A in CRC patients significantly correlated with improved disease-free survival (p = 0.0055), supporting the belief that RPL37A may play a role in cell death, as suggested in glioblastoma [63]. The gene discussed is RPL37A; the disease is glioblastoma.